Clinical Trials

190 enrolled 12 charts

Phase 1 Active not recruiting

Breast Neoplasms

NCT03218826 2025-10-30

PI3Kbeta Inhibitor AZD8186 and Docetaxel in Treating Patients Advanced Solid Tumors With PTEN or PIK3CB Mutations That Are Metastatic or Cannot Be Removed by Surgery

23 enrolled 15 charts

BreastGenitourinary

Breast Neoplasms, Neoplasm Metastasis, Prostatic Neoplasms, Triple Negative Breast Neoplasms

NCT01275677 2025-07-14

Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer

3,270 enrolled 16 charts

Breast Neoplasms

NCT00063934 2019-03-05

Oblimersen Plus Doxorubicin and Docetaxel in Treating Patients With Metastatic or Locally Advanced Breast Cancer

Phase 1/2 Terminated

31 enrolled 8 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT00070252 2015-05-04

Neoadjuvant Tipifarnib, Docetaxel, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIA or Stage IIIB Breast Cancer

Phase 1/2 Completed

53 enrolled

Breast Neoplasms, Breast Neoplasms, Male, Inflammatory Breast Neoplasms

NCT00003066 2014-01-06

Docetaxel Combined With Estramustine in Treating Women With Metastatic Breast Cancer

40 enrolled

Breast Neoplasms

NCT00012311 2014-01-06

Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Chemotherapy Alone in Treating Women With Stage IV Breast Cancer

Breast Neoplasms

NCT00010140 2013-12-18

Epirubicin and Tamoxifen With or Without Docetaxel in Treating Postmenopausal Women With Breast Cancer

Phase 3 Unknown

Breast Neoplasms

NCT00003679 2013-11-06

Combination Chemotherapy in Treating Women With Breast Cancer

Phase 3 Unknown

350 enrolled

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00288002 2013-08-26

Combination Chemotherapy With or Without Capecitabine and/or Trastuzumab Before Surgery in Treating Women With Stage I, Stage II, or Stage III Breast Cancer

1,500 enrolled

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00321633 2013-08-26

Carboplatin or Docetaxel in Treating Women With Metastatic Genetic Breast Cancer

148 enrolled

BreastGynecologic

Breast Neoplasms, Hereditary Breast and Ovarian Cancer Syndrome

NCT00963729 2013-08-12

Chemotherapy or Letrozole Before Surgery in Treating Postmenopausal Women With Breast Cancer That Can Be Removed By Surgery

756 enrolled

Breast Neoplasms

NCT00026078 2013-08-07

Docetaxel and Ifosfamide in Treating Women With Metastatic Breast Cancer

42 enrolled

Breast Neoplasms

NCT00629278 2013-08-07

Combination Chemotherapy and Trastuzumab in Treating Women With Stage I, Stage II, or Stage III HER2-Positive Breast Cancer

Phase 3 Unknown

2,500 enrolled

Breast Neoplasms

NCT00002544 2013-08-02

Mitoxantrone With or Without Docetaxel in Treating Women With Metastatic Breast Cancer

300 enrolled

Breast Neoplasms

NCT00002662 2013-08-02

Paclitaxel or Docetaxel in Treating Women With Advanced Breast Cancer

Breast Neoplasms

NCT00311636 2013-06-26

Triptorelin in Preventing Early Menopause in Premenopausal Women Who Are Receiving Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By Surgery

280 enrolled

Breast Neoplasms

NCT00079170 2013-06-20

Docetaxel Plus Garlic in Treating Patients With Locally Advanced or Metastatic Breast Cancer

Phase NA Completed

Breast Neoplasms, Breast Neoplasms, Male

NCT00020332 2013-06-17

Docetaxel and Flavopiridol in Treating Patients With Locally Advanced or Metastatic Breast Cancer

Phase 1/2 Completed

Breast Neoplasms, Breast Neoplasms, Male

NCT00055861 2013-06-04

Bevacizumab and Docetaxel in Treating Women With Locally Advanced or Metastatic Breast Cancer

27 enrolled

Breast Neoplasms

NCT00004906 2013-05-30

Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer

Breast Neoplasms

NCT00044993 2013-05-30

Chemotherapy Combined With Gene Therapy in Treating Patients Who Have Stage III or Stage IV Breast Cancer

Breast Neoplasms, Breast Neoplasms, Male

NCT00047099 2013-05-30

Combination Chemotherapy in Treating Women With Breast Cancer

446 enrolled

Breast Neoplasms

NCT00005908 2013-03-19

Primary Chemotherapy With Docetaxel-Capecitabine and Doxorubicin-Cyclophosphamide in Breast Cancer

30 enrolled 12 charts

Breast Neoplasms

NCT00398489 2010-11-09

Docetaxel, Epirubicin, and Cyclophosphamide With or Without Trastuzumab in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery

94 enrolled

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00994968 2010-10-29

Doxorubicin Hydrochloride, Cyclophosphamide, Docetaxel, and S-1 Before Surgery in Treating Women With Stage II or Stage III Breast Cancer

49 enrolled

Breast Neoplasms

NCT00801411 2009-06-17

Cyclophosphamide and Docetaxel or Doxorubicin in Treating Women With Newly Diagnosed Breast Cancer That Can Be Removed by Surgery

318 enrolled

Breast Neoplasms

NCT00033683 2009-02-09

Combination Chemotherapy in Treating Women With Resected Breast Cancer

Breast Neoplasms

NCT00006120 2008-07-24

Docetaxel or Paclitaxel in Treating Women With Unresectable Locally Advanced or Metastatic Breast Cancer